MONTREAL, April 30 /CNW Telbec/ - Biophage Pharma Inc. (TSX: BUG.V), a high-potential, revenue-driven biotechnology company focused on the development of an integrated approach for the prevention and control of bacterial infections, reported today its financial results for its first quarter ended February 28, 2007.
